Publication:
Imatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia

Simple item page
dc.contributor.coauthorŞimşek, Eda Tanrıkulu
dc.contributor.coauthorEskazan, Ahmet Emre
dc.contributor.coauthorCengiz, Mahir
dc.contributor.coauthorAr, M. Cem
dc.contributor.coauthorEkizoğlu, Seda
dc.contributor.coauthorSalihoğlu, Ayşe
dc.contributor.coauthorGültürk, Emine
dc.contributor.coauthorElverdi, Tuğrul
dc.contributor.coauthorAydın, Seniz Öngören
dc.contributor.coauthorDemiröz, Ahu Senem
dc.contributor.coauthorBuyru, Ayşe Nur
dc.contributor.coauthorBaşlar, Zafer
dc.contributor.coauthorÖzbek, Uğur
dc.contributor.coauthorFerhanoğlu, A. Burhan
dc.contributor.coauthorAydın, Yıldız
dc.contributor.coauthorTüzüner, Nükhet
dc.contributor.coauthorSoysal, Teoman
dc.contributor.kuauthorFerhanoğlu, Ahmet Burhan
dc.contributor.kuprofileFaculty Member
dc.contributor.schoolcollegeinstituteSchool of Medicine
dc.contributor.yokid18320
dc.date.accessioned2024-11-09T23:05:02Z
dc.date.issued2015
dc.description.indexedbyWoS
dc.description.issue23
dc.description.openaccessNO
dc.description.publisherscopeInternational
dc.description.sponsoredbyTubitakEuN/A
dc.description.volume126
dc.identifier.doiN/A
dc.identifier.eissn1528-0020
dc.identifier.issn0006-4971
dc.identifier.quartileQ1
dc.identifier.urihttps://hdl.handle.net/20.500.14288/8743
dc.languageEnglish
dc.publisherAmerican Society Hematology
dc.sourceBlood
dc.subjectHematology
dc.titleImatinib mesylate reduces bone marrow fibrosis and overwhelms the adverse prognostic impact of reticulin formation in patients with chronic myeloid leukemia
dc.typeMeeting Abstract
dspace.entity.typePublication
local.contributor.authorid0000-0002-4257-549X
local.contributor.kuauthorFerhanoğlu, Ahmet Burhan

Files

Collections

Publications without Fulltext